Literature DB >> 20562307

Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores.

Norma Ramirez1, Marc Liggins, Ernesto Abel-Santos.   

Abstract

Clostridium difficile is a spore-forming bacterium that causes Clostridium difficile-associated disease (CDAD). Intestinal microflora keeps C. difficile in the spore state and prevents colonization. Following antimicrobial treatment, the microflora is disrupted, and C. difficile spores germinate in the intestines. The resulting vegetative cells are believed to fill empty niches left by the depleted microbial community and establish infection. Thus, germination of C. difficile spores is the first required step in CDAD. Interestingly, C. difficile genes encode most known spore-specific protein necessary for germination, except for germination (Ger) receptors. Even though C. difficile Ger receptors have not been identified, taurocholate (a bile salt) and glycine (an amino acid) have been shown to be required for spore germination. Furthermore, chenodeoxycholate, another bile salt, can inhibit taurocholate-induced C. difficile spore germination. In the present study, we examined C. difficile spore germination kinetics to determine whether taurocholate acts as a specific germinant that activates unknown germination receptors or acts nonspecifically by disrupting spores' membranes. Kinetic analysis of C. difficile spore germination suggested the presence of distinct receptors for taurocholate and glycine. Furthermore, taurocholate, glycine, and chenodeoxycholate seem to bind to C. difficile spores through a complex mechanism, where both receptor homo- and heterocomplexes are formed. The kinetic data also point to an ordered sequential progression of binding where taurocholate must be recognized first before detection of glycine can take place. Finally, comparing calculated kinetic parameters with intestinal concentrations of the two germinants suggests a mechanism for the preferential germination of C. difficile spores in antibiotic-treated individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562307      PMCID: PMC2916422          DOI: 10.1128/JB.00488-10

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  42 in total

Review 1.  A comparative genomic view of clostridial sporulation and physiology.

Authors:  Carlos J Paredes; Keith V Alsaker; Eleftherios T Papoutsakis
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

2.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Authors:  Mohammed Sebaihia; Brendan W Wren; Peter Mullany; Neil F Fairweather; Nigel Minton; Richard Stabler; Nicholas R Thomson; Adam P Roberts; Ana M Cerdeño-Tárraga; Hongmei Wang; Matthew T G Holden; Anne Wright; Carol Churcher; Michael A Quail; Stephen Baker; Nathalie Bason; Karen Brooks; Tracey Chillingworth; Ann Cronin; Paul Davis; Linda Dowd; Audrey Fraser; Theresa Feltwell; Zahra Hance; Simon Holroyd; Kay Jagels; Sharon Moule; Karen Mungall; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Mark Simmonds; Kim Stevens; Louise Unwin; Sally Whithead; Bruno Dupuy; Gordon Dougan; Bart Barrell; Julian Parkhill
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

Review 3.  Diagnosis and treatment of Clostridium difficile colitis.

Authors:  R Fekety; A B Shah
Journal:  JAMA       Date:  1993-01-06       Impact factor: 56.272

4.  The development of Clostridium difficile genetic systems.

Authors:  Nigel Minton; Glen Carter; Mike Herbert; Triona O'keeffe; Des Purdy; Mike Elmore; Anna Ostrowski; Oliver Pennington; Ian Davis
Journal:  Anaerobe       Date:  2004-04       Impact factor: 3.331

5.  Germination of Bacillus cereus spores in response to L-alanine and to inosine: the roles of gerL and gerQ operons.

Authors:  Paul J Barlass; Christopher W Houston; Mark O Clements; Anne Moir
Journal:  Microbiology       Date:  2002-07       Impact factor: 2.777

6.  Determination of intralumenal individual bile acids by HPLC with charged aerosol detection.

Authors:  Maria Vertzoni; Helen Archontaki; Christos Reppas
Journal:  J Lipid Res       Date:  2008-08-07       Impact factor: 5.922

7.  Characterization of fatty acid composition, spore germination, and thermal resistance in a nisin-resistant mutant of Clostridium botulinum 169B and in the wild-type strain.

Authors:  A S Mazzotta; T J Montville
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

8.  Human cecal bile acids: concentration and spectrum.

Authors:  James P Hamilton; Guofeng Xie; Jean-Pierre Raufman; Susan Hogan; Terrance L Griffin; Christine A Packard; Dale A Chatfield; Lee R Hagey; Joseph H Steinbach; Alan F Hofmann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-04-05       Impact factor: 4.052

9.  Clostridium perfringens spore germination: characterization of germinants and their receptors.

Authors:  Daniel Paredes-Sabja; J Antonio Torres; Peter Setlow; Mahfuzur R Sarker
Journal:  J Bacteriol       Date:  2007-12-14       Impact factor: 3.490

10.  Dissecting interactions between nucleosides and germination receptors in Bacillus cereus 569 spores.

Authors:  Tetyana Dodatko; Monique Akoachere; Nadia Jimenez; Zadkiel Alvarez; Ernesto Abel-Santos
Journal:  Microbiology (Reading)       Date:  2009-12-24       Impact factor: 2.777

View more
  33 in total

1.  Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination.

Authors:  Kristen L Stoltz; Raymond Erickson; Christopher Staley; Alexa R Weingarden; Erin Romens; Clifford J Steer; Alexander Khoruts; Michael J Sadowsky; Peter I Dosa
Journal:  J Med Chem       Date:  2017-04-12       Impact factor: 7.446

2.  Mapping interactions between germinants and Clostridium difficile spores.

Authors:  Amber Howerton; Norma Ramirez; Ernesto Abel-Santos
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

Review 3.  Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.

Authors:  Jenessa A Winston; Casey M Theriot
Journal:  Anaerobe       Date:  2016-05-07       Impact factor: 3.331

4.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

5.  Contribution of spores to the ability of Clostridium difficile to adhere to surfaces.

Authors:  Lovleen Tina Joshi; Daniel S Phillips; Catrin F Williams; Abdullah Alyousef; Les Baillie
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

Review 6.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

Review 7.  Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission.

Authors:  Aimee Shen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

8.  Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases.

Authors:  Kentaro Oka; Takako Osaki; Tomoko Hanawa; Satoshi Kurata; Mitsuhiro Okazaki; Taki Manzoku; Motomichi Takahashi; Mamoru Tanaka; Haruhiko Taguchi; Takashi Watanabe; Takashi Inamatsu; Shigeru Kamiya
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

9.  A Clostridium difficile alanine racemase affects spore germination and accommodates serine as a substrate.

Authors:  Ritu Shrestha; Steve W Lockless; Joseph A Sorg
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

10.  Spore Cortex Hydrolysis Precedes Dipicolinic Acid Release during Clostridium difficile Spore Germination.

Authors:  Michael B Francis; Charlotte A Allen; Joseph A Sorg
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.